KZIA

Kazia Therapeutics
KZIA

Overview Fund Activity

5 hedge funds and large institutions have $233K invested in Kazia Therapeutics in 2017 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 2 closing their positions.

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$119K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$103K
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$4K
5
UBS Group
5
UBS Group
Switzerland
$7K
Name Market Value Shares Shares
Change 		Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$119K 39,500 -105,600 -73%
Renaissance Technologies
2
Renaissance Technologies
New York
$103K 34,325 -102,975 -75%
UBS Group
3
UBS Group
Switzerland
$7K 2,040 -26 -1%
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$4K 1,250 -3,750 -75%
Citadel Advisors
5
Citadel Advisors
Florida
– – -18,094 Closed
Creative Planning
6
Creative Planning
Kansas
– – -200 Closed
Bank of America
7
Bank of America
North Carolina
$0 201 -19 -9%